148 related articles for article (PubMed ID: 30226481)
1. Low expression of MUC2 is associated with longer disease-free survival in patients with colorectal carcinoma.
Al-Maghrabi J; Sultana S; Gomaa W
Saudi J Gastroenterol; 2019; 25(1):61-66. PubMed ID: 30226481
[TBL] [Abstract][Full Text] [Related]
2. Expression of clusterin in colorectal carcinoma in relation to clinicopathological criteria.
Gomaa W; Al-Ahwal M; Al-Maghrabi H; Buhmeida A; Al-Qahtani M; Al-Maghrabi B; Al-Maghrabi J
Malays J Pathol; 2017 Dec; 39(3):243-250. PubMed ID: 29279586
[TBL] [Abstract][Full Text] [Related]
3. Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma.
Elzagheid A; Emaetig F; Buhmeida A; Laato M; El-Faitori O; Syrjänen K; Collan Y; Pyrhönen S
Tumour Biol; 2013 Apr; 34(2):621-8. PubMed ID: 23179399
[TBL] [Abstract][Full Text] [Related]
4. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
5. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
7. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.
Al-Maghrabi J; Gomaa W; Buhmeida A; Al-Qahtani M; Al-Ahwal M
Anticancer Res; 2012 Aug; 32(8):3455-61. PubMed ID: 22843930
[TBL] [Abstract][Full Text] [Related]
8. Expression of leptin in colorectal adenocarcinoma showed significant different survival patterns associated with tumor size, lymphovascular invasion, distant metastasis, local recurrence, and relapse of disease in the western province of Saudi Arabia.
Al-Maghrabi JA; Qureshi IA; Khabaz MN
Medicine (Baltimore); 2018 Aug; 97(34):e12052. PubMed ID: 30142858
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles.
Al-Maghrabi J; Emam E; Gomaa W
Saudi J Gastroenterol; 2018; 24(2):129-134. PubMed ID: 29637921
[TBL] [Abstract][Full Text] [Related]
10. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
[TBL] [Abstract][Full Text] [Related]
11. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence.
Al-Maghrabi J; Emam E; Gomaa W; Saggaf M; Buhmeida A; Al-Qahtani M; Al-Ahwal M
BMC Cancer; 2015 Oct; 15():676. PubMed ID: 26459369
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
[TBL] [Abstract][Full Text] [Related]
13. Diverse expression patterns of mucin 2 in colorectal cancer indicates its mechanism related to the intestinal mucosal barrier.
Gan GL; Wu HT; Chen WJ; Li CL; Ye QQ; Zheng YF; Liu J
World J Gastroenterol; 2021 Jul; 27(25):3888-3900. PubMed ID: 34321852
[TBL] [Abstract][Full Text] [Related]
14. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Cyclin D1 Over-expression in Colorectal Cancer: An Experience from Madinah, Saudi Arabia.
Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2471-2476. PubMed ID: 31450922
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.
Al-Maghrabi J; Emam E; Gomaa W; Al-Qaydy D; Al-Maghrabi B; Buhmeida A; Abuzenadah A; Al-Qahtani M; Al-Ahwal M
Int J Clin Exp Pathol; 2015; 8(12):15895-902. PubMed ID: 26884861
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients.
Ribeirinho-Soares S; Pádua D; Amaral AL; Valentini E; Azevedo D; Marques C; Barros R; Macedo F; Mesquita P; Almeida R
BMC Cancer; 2021 Apr; 21(1):359. PubMed ID: 33823840
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma.
Al-Maghrabi J; Gomaa W; Buhmeida A; Qari Y; Al-Qahtani M; Al-Ahwal M
Tumour Biol; 2014 Sep; 35(9):9045-51. PubMed ID: 24908415
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of androgen receptor overexpression in colorectal cancer. Experience from Al-Madinah Al-Munawarah, Saudi Arabia.
Albasri AM; Elkablawy MA
Saudi Med J; 2019 Sep; 40(9):893-900. PubMed ID: 31522216
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
